25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

531349 (Panacea Biotec Limited) Stock Analysis
Buy, Hold or Sell?

Let's analyze Panacea Biotec Limited together

I guess you are interested in Panacea Biotec Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Panacea Biotec Limited’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Panacea Biotec Limited’s Price Targets

I'm going to help you getting a better view of Panacea Biotec Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Panacea Biotec Limited

I send you an email if I find something interesting about Panacea Biotec Limited.

1. Quick Overview

1.1. Quick analysis of Panacea Biotec Limited (30 sec.)










1.2. What can you expect buying and holding a share of Panacea Biotec Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR137.73
Expected worth in 1 year
INR116.16
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
INR-21.57
Return On Investment
-5.1%

For what price can you sell your share?

Current Price per Share
INR424.90
Expected price per share
INR278.40 - INR495.15
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Panacea Biotec Limited (5 min.)




Live pricePrice per Share (EOD)
INR424.90
Intrinsic Value Per Share
INR-1,057.49 - INR-642.35
Total Value Per Share
INR-919.76 - INR-504.62

2.2. Growth of Panacea Biotec Limited (5 min.)




Is Panacea Biotec Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$98.7m$102.5m-$3.8m-3.9%

How much money is Panacea Biotec Limited making?

Current yearPrevious yearGrowGrow %
Making money-$3.8m$126.1m-$130m-3,343.0%
Net Profit Margin-7.2%163.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Panacea Biotec Limited (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#343 / 872

Most Revenue
#118 / 872

Most Profit
#238 / 872

Most Efficient
#390 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Panacea Biotec Limited?

Welcome investor! Panacea Biotec Limited's management wants to use your money to grow the business. In return you get a share of Panacea Biotec Limited.

First you should know what it really means to hold a share of Panacea Biotec Limited. And how you can make/lose money.

Speculation

The Price per Share of Panacea Biotec Limited is INR424.90. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Panacea Biotec Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Panacea Biotec Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR137.73. Based on the TTM, the Book Value Change Per Share is INR-5.39 per quarter. Based on the YOY, the Book Value Change Per Share is INR180.46 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Panacea Biotec Limited.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.060.0%-0.060.0%2.060.5%0.570.1%0.280.1%0.070.0%
Usd Book Value Change Per Share-0.060.0%-0.060.0%2.110.5%0.410.1%0.200.0%0.160.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.060.0%-0.060.0%2.110.5%0.410.1%0.200.0%0.160.0%
Usd Price Per Share1.27-1.27-1.73-1.69-1.74-1.75-
Price to Earnings Ratio-19.97--19.97-0.84--8.83-0.45--8.23-
Price-to-Total Gains Ratio-20.09--20.09-0.82--7.27-0.57--7.91-
Price to Book Ratio0.79-0.79-1.04--0.98-0.78-1.63-
Price-to-Total Gains Ratio-20.09--20.09-0.82--7.27-0.57--7.91-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.97133
Number of shares201
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.060.20
Usd Total Gains Per Share-0.060.20
Gains per Quarter (201 shares)-12.6841.08
Gains per Year (201 shares)-50.73164.30
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-51-610164154
20-101-1120329318
30-152-1630493482
40-203-2140657646
50-254-2650822810
60-304-3160986974
70-355-367011501138
80-406-418013141302
90-457-469014791466
100-507-520016431630

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.08.00.020.0%2.08.00.020.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.07.00.030.0%3.07.00.030.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.010.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.07.00.030.0%3.07.00.030.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Panacea Biotec Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---5.393-5.3930%180.460-103%35.091-115%17.466-131%13.773-139%
Book Value Per Share--137.729137.7290%143.122-4%81.172+70%66.635+107%66.964+106%
Current Ratio--1.7131.7130%1.276+34%1.375+25%1.106+55%0.973+76%
Debt To Asset Ratio--0.3360.3360%0.502-33%0.677-50%0.727-54%0.751-55%
Debt To Equity Ratio--0.5070.5070%1.006-50%0.504+0%2.087-76%2.815-82%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--4435658762.5004435658762.5000%5750983687.500-23%2825758500.000+57%1270560255.000+249%-1704740841.500+138%
Eps---5.426-5.4260%175.979-103%48.813-111%24.177-122%6.123-189%
Ev To Sales Ratio--0.9640.9640%0.870+11%0.520+85%0.249+287%-0.272+128%
Free Cash Flow Per Share---75.656-75.6560%-19.746-74%-27.181-64%-14.265-81%-1.971-97%
Free Cash Flow To Equity Per Share---78.656-78.6560%-211.720+169%-94.736+20%-55.137-30%-29.259-63%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---642.345----------
Intrinsic Value_10Y_min---1057.487----------
Intrinsic Value_1Y_max---25.123----------
Intrinsic Value_1Y_min---47.527----------
Intrinsic Value_3Y_max---105.393----------
Intrinsic Value_3Y_min---194.262----------
Intrinsic Value_5Y_max---221.722----------
Intrinsic Value_5Y_min---396.273----------
Market Cap26025422430.000+74%6636518762.5006636518762.5000%9080423687.500-27%8860941833.333-25%9085936255.000-27%9171073158.500-28%
Net Profit Margin---0.072-0.0720%1.630-104%0.440-116%0.209-135%0.042-271%
Operating Margin----0%-0%-0%0.083-100%0.053-100%
Operating Ratio--0.6760.6760%0.511+32%0.534+27%0.725-7%1.074-37%
Pb Ratio3.085+74%0.7870.7870%1.036-24%-0.976+224%0.782+1%1.631-52%
Pe Ratio-78.303-292%-19.967-19.9670%0.842-2470%-8.827-56%0.449-4549%-8.226-59%
Price Per Share424.900+74%108.350108.3500%148.250-27%144.667-25%148.340-27%149.730-28%
Price To Free Cash Flow Ratio-5.616-292%-1.432-1.4320%-7.508+424%1.287-211%-0.405-72%-20.120+1305%
Price To Total Gains Ratio-78.786-292%-20.091-20.0910%0.822-2546%-7.270-64%0.574-3601%-7.910-61%
Quick Ratio--1.3221.3220%1.455-9%1.109+19%0.794+67%0.496+166%
Return On Assets---0.026-0.0260%0.613-104%0.154-117%0.070-137%0.015-275%
Return On Equity---0.039-0.0390%1.230-103%0.397-110%0.064-161%-0.057+45%
Total Gains Per Share---5.393-5.3930%180.460-103%35.091-115%17.466-131%13.773-139%
Usd Book Value--98701551.00098701551.0000%102566412.000-4%58170294.000+70%47753152.200+107%47988369.000+106%
Usd Book Value Change Per Share---0.063-0.0630%2.111-103%0.411-115%0.204-131%0.161-139%
Usd Book Value Per Share--1.6111.6110%1.675-4%0.950+70%0.780+107%0.783+106%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--51897207.52151897207.5210%67286509.144-23%33061374.450+57%14865554.984+249%-19945467.846+138%
Usd Eps---0.063-0.0630%2.059-103%0.571-111%0.283-122%0.072-189%
Usd Free Cash Flow---54217566.000-54217566.0000%-14150565.000-74%-19478784.000-64%-10222477.200-81%-1412622.900-97%
Usd Free Cash Flow Per Share---0.885-0.8850%-0.231-74%-0.318-64%-0.167-81%-0.023-97%
Usd Free Cash Flow To Equity Per Share---0.920-0.9200%-2.477+169%-1.108+20%-0.645-30%-0.342-63%
Usd Market Cap304497442.431+74%77647269.52177647269.5210%106240957.144-27%103673019.450-25%106305454.184-27%107301555.954-28%
Usd Price Per Share4.971+74%1.2681.2680%1.735-27%1.693-25%1.736-27%1.752-28%
Usd Profit---3888729.000-3888729.0000%126112545.000-103%34981128.000-111%17325804.600-122%4387932.900-189%
Usd Revenue--53813682.00053813682.0000%77364144.000-30%68093337.000-21%64273692.600-16%67287998.700-20%
Usd Total Gains Per Share---0.063-0.0630%2.111-103%0.411-115%0.204-131%0.161-139%
 EOD+5 -3MRQTTM+0 -0YOY+9 -263Y+14 -215Y+14 -2210Y+15 -21

3.3 Fundamental Score

Let's check the fundamental score of Panacea Biotec Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-78.303
Price to Book Ratio (EOD)Between0-13.085
Net Profit Margin (MRQ)Greater than0-0.072
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.322
Current Ratio (MRQ)Greater than11.713
Debt to Asset Ratio (MRQ)Less than10.336
Debt to Equity Ratio (MRQ)Less than10.507
Return on Equity (MRQ)Greater than0.15-0.039
Return on Assets (MRQ)Greater than0.05-0.026
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Panacea Biotec Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.267
Ma 20Greater thanMa 50418.090
Ma 50Greater thanMa 100467.831
Ma 100Greater thanMa 200446.431
OpenGreater thanClose418.850
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Panacea Biotec Limited

Panacea Biotec Limited, a biotechnology company, researches and develops, manufactures, markets, and sells pharmaceuticals, vaccines, and biosimilar in India. The company operates through Vaccines, Formulations, and Research and Development segments. Its product portfolio includes prescription products in various therapeutic areas, including pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, and gastro-intestinal care products, as well as vaccines. The company also exports its products to the Commonwealth of Independent States, Africa, the Middle East, and Asia. It has a collaboration agreement with Refana Inc. for the development, manufacturing, and distribution of the Covid-19 vaccine. Panacea Biotec Limited was founded in 1984 and is based in New Delhi, India.

Fundamental data was last updated by Penke on 2025-06-24 21:09:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Panacea Biotec Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compareΒ Panacea Biotec Limited to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -7.2%Β means thatΒ ₹-0.07 for each ₹1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Panacea Biotec Limited:

  • The MRQ is -7.2%. The company is making a loss. -1
  • The TTM is -7.2%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-7.2%TTM-7.2%0.0%
TTM-7.2%YOY163.0%-170.2%
TTM-7.2%5Y20.9%-28.2%
5Y20.9%10Y4.2%+16.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.2%-91.7%+84.5%
TTM-7.2%-140.3%+133.1%
YOY163.0%-196.4%+359.4%
3Y44.0%-247.9%+291.9%
5Y20.9%-343.3%+364.2%
10Y4.2%-488.1%+492.3%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Panacea Biotec Limited is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Panacea Biotec Limited to theΒ Biotechnology industry mean.
  • -2.6% Return on Assets means thatΒ Panacea Biotec Limited generatedΒ ₹-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Panacea Biotec Limited:

  • The MRQ is -2.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-2.6%0.0%
TTM-2.6%YOY61.3%-63.9%
TTM-2.6%5Y7.0%-9.6%
5Y7.0%10Y1.5%+5.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.6%-11.5%+8.9%
TTM-2.6%-11.5%+8.9%
YOY61.3%-11.4%+72.7%
3Y15.4%-11.7%+27.1%
5Y7.0%-11.9%+18.9%
10Y1.5%-13.7%+15.2%
4.3.1.3. Return on Equity

Shows how efficient Panacea Biotec Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Panacea Biotec Limited to theΒ Biotechnology industry mean.
  • -3.9% Return on Equity means Panacea Biotec Limited generated ₹-0.04Β for eachΒ ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Panacea Biotec Limited:

  • The MRQ is -3.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.9%TTM-3.9%0.0%
TTM-3.9%YOY123.0%-126.9%
TTM-3.9%5Y6.4%-10.4%
5Y6.4%10Y-5.7%+12.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.9%-13.6%+9.7%
TTM-3.9%-14.8%+10.9%
YOY123.0%-14.4%+137.4%
3Y39.7%-16.8%+56.5%
5Y6.4%-17.5%+23.9%
10Y-5.7%-19.5%+13.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Panacea Biotec Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Panacea Biotec Limited is operatingΒ .

  • Measures how much profit Panacea Biotec Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Panacea Biotec Limited to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated ₹0.00 Β for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Panacea Biotec Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y8.3%-8.3%
5Y8.3%10Y5.3%+3.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--221.8%+221.8%
TTM--250.7%+250.7%
YOY--208.5%+208.5%
3Y--220.2%+220.2%
5Y8.3%-342.4%+350.7%
10Y5.3%-462.5%+467.8%
4.3.2.2. Operating Ratio

Measures how efficient Panacea Biotec Limited is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.68 means that the operating costs are ₹0.68 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Panacea Biotec Limited:

  • The MRQ is 0.676. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.676. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.676TTM0.6760.000
TTM0.676YOY0.511+0.165
TTM0.6765Y0.725-0.049
5Y0.72510Y1.074-0.349
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6762.097-1.421
TTM0.6762.684-2.008
YOY0.5113.076-2.565
3Y0.5343.524-2.990
5Y0.7254.724-3.999
10Y1.0746.445-5.371
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Panacea Biotec Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Panacea Biotec Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 1.71Β means the company has ₹1.71 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Panacea Biotec Limited:

  • The MRQ is 1.713. The company is able to pay all its short-term debts. +1
  • The TTM is 1.713. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.713TTM1.7130.000
TTM1.713YOY1.276+0.437
TTM1.7135Y1.106+0.607
5Y1.10610Y0.973+0.133
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7133.638-1.925
TTM1.7133.846-2.133
YOY1.2764.140-2.864
3Y1.3754.688-3.313
5Y1.1065.722-4.616
10Y0.9736.144-5.171
4.4.3.2. Quick Ratio

Measures if Panacea Biotec Limited is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Panacea Biotec Limited to theΒ Biotechnology industry mean.
  • A Quick Ratio of 1.32Β means the company can pay off ₹1.32 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Panacea Biotec Limited:

  • The MRQ is 1.322. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.322. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.322TTM1.3220.000
TTM1.322YOY1.455-0.133
TTM1.3225Y0.794+0.528
5Y0.79410Y0.496+0.297
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3222.826-1.504
TTM1.3223.116-1.794
YOY1.4553.786-2.331
3Y1.1094.311-3.202
5Y0.7945.702-4.908
10Y0.4966.335-5.839
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Panacea Biotec Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Panacea Biotec LimitedΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Panacea Biotec Limited to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.34Β means that Panacea Biotec Limited assets areΒ financed with 33.6% credit (debt) and the remaining percentage (100% - 33.6%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Panacea Biotec Limited:

  • The MRQ is 0.336. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.336. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.336TTM0.3360.000
TTM0.336YOY0.502-0.165
TTM0.3365Y0.727-0.391
5Y0.72710Y0.751-0.024
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3360.327+0.009
TTM0.3360.349-0.013
YOY0.5020.332+0.170
3Y0.6770.340+0.337
5Y0.7270.346+0.381
10Y0.7510.378+0.373
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Panacea Biotec Limited is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Panacea Biotec Limited to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 50.7% means that company has ₹0.51 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Panacea Biotec Limited:

  • The MRQ is 0.507. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.507. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.507TTM0.5070.000
TTM0.507YOY1.006-0.500
TTM0.5075Y2.087-1.580
5Y2.08710Y2.815-0.728
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5070.383+0.124
TTM0.5070.438+0.069
YOY1.0060.414+0.592
3Y0.5040.450+0.054
5Y2.0870.457+1.630
10Y2.8150.512+2.303
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every ₹1 in earnings Panacea Biotec Limited generates.

  • Above 15 is considered overpriced butΒ always compareΒ Panacea Biotec Limited to theΒ Biotechnology industry mean.
  • A PE ratio of -19.97 means the investor is paying ₹-19.97Β for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Panacea Biotec Limited:

  • The EOD is -78.303. Based on the earnings, the company is expensive. -2
  • The MRQ is -19.967. Based on the earnings, the company is expensive. -2
  • The TTM is -19.967. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-78.303MRQ-19.967-58.335
MRQ-19.967TTM-19.9670.000
TTM-19.967YOY0.842-20.810
TTM-19.9675Y0.449-20.416
5Y0.44910Y-8.226+8.674
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-78.303-2.399-75.904
MRQ-19.967-2.092-17.875
TTM-19.967-2.625-17.342
YOY0.842-3.784+4.626
3Y-8.827-3.762-5.065
5Y0.449-6.363+6.812
10Y-8.226-7.055-1.171
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Panacea Biotec Limited:

  • The EOD is -5.616. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.432. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.432. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.616MRQ-1.432-4.184
MRQ-1.432TTM-1.4320.000
TTM-1.432YOY-7.508+6.076
TTM-1.4325Y-0.405-1.027
5Y-0.40510Y-20.120+19.715
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.616-3.299-2.317
MRQ-1.432-2.742+1.310
TTM-1.432-3.801+2.369
YOY-7.508-4.402-3.106
3Y1.287-5.140+6.427
5Y-0.405-8.483+8.078
10Y-20.120-9.296-10.824
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Panacea Biotec Limited is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 0.79 means the investor is paying ₹0.79Β for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Panacea Biotec Limited:

  • The EOD is 3.085. Based on the equity, the company is fair priced.
  • The MRQ is 0.787. Based on the equity, the company is cheap. +2
  • The TTM is 0.787. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.085MRQ0.787+2.298
MRQ0.787TTM0.7870.000
TTM0.787YOY1.036-0.249
TTM0.7875Y0.782+0.005
5Y0.78210Y1.631-0.850
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.0852.113+0.972
MRQ0.7871.856-1.069
TTM0.7872.125-1.338
YOY1.0362.454-1.418
3Y-0.9762.492-3.468
5Y0.7823.668-2.886
10Y1.6314.364-2.733
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets12,711,660
Total Liabilities4,275,630
Total Stockholder Equity8,436,030
 As reported
Total Liabilities 4,275,630
Total Stockholder Equity+ 8,436,030
Total Assets = 12,711,660

Assets

Total Assets12,711,660
Total Current Assets5,683,200
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 362,300
Short-term Investments 1,712,050
Net Receivables 600,920
Inventory 2,056,030
Other Current Assets 404,220
Total Current Assets  (as reported)5,683,200
Total Current Assets  (calculated)5,135,520
+/- 547,680
Long-term Assets
Property Plant Equipment 6,163,350
Intangible Assets 259,410
Long-term Assets  (as reported)0
Long-term Assets  (calculated)6,422,760
+/- 6,422,760

Liabilities & Shareholders' Equity

Total Current Liabilities3,318,310
Long-term Liabilities0
Total Stockholder Equity8,436,030
Total Current Liabilities
Total Current Liabilities  (as reported)3,318,310
Total Current Liabilities  (calculated)0
+/- 3,318,310
Long-term Liabilities
Long term Debt Total 201,640
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)201,640
+/- 201,640
Total Stockholder Equity
Common Stock61,250
Retained Earnings 7,397,680
Capital Surplus 919,400
Other Stockholders Equity 57,700
Total Stockholder Equity (as reported)8,436,030
Total Stockholder Equity (calculated)8,436,030
+/-0
Other
Cash And Equivalents420
Cash and Short Term Investments 2,074,770
Common Stock Shares Outstanding 61,251
Liabilities and Stockholders Equity 12,711,660
Net Working Capital 2,364,890



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
19,433,500
19,304,700
18,029,880
18,001,380
16,075,560
13,755,200
13,903,000
11,775,320
17,588,690
12,711,660
12,711,66017,588,69011,775,32013,903,00013,755,20016,075,56018,001,38018,029,88019,304,70019,433,500
   > Total Current Assets 
3,728,100
5,257,200
6,637,430
6,997,250
5,603,460
5,078,860
3,595,000
5,109,720
9,905,500
5,683,200
5,683,2009,905,5005,109,7203,595,0005,078,8605,603,4606,997,2506,637,4305,257,2003,728,100
       Cash And Cash Equivalents 
247,800
524,000
229,300
239,000
164,370
144,660
402,200
520,790
503,500
362,300
362,300503,500520,790402,200144,660164,370239,000229,300524,000247,800
       Short-term Investments 
0
49,800
35,200
2,700
20,290
90,140
495,330
129,070
4,989,390
1,712,050
1,712,0504,989,390129,070495,33090,14020,2902,70035,20049,8000
       Net Receivables 
1,010,100
1,053,300
1,233,710
1,421,710
1,360,100
887,300
685,200
846,840
816,560
600,920
600,920816,560846,840685,200887,3001,360,1001,421,7101,233,7101,053,3001,010,100
       Inventory 
2,198,100
3,102,200
3,075,330
3,155,540
3,342,060
814,270
1,476,900
1,741,370
2,190,230
2,056,030
2,056,0302,190,2301,741,3701,476,900814,2703,342,0603,155,5403,075,3303,102,2002,198,100
       Other Current Assets 
227,600
497,500
1,748,750
1,739,120
141,210
2,756,390
429,100
1,014,560
830,710
404,220
404,220830,7101,014,560429,1002,756,390141,2101,739,1201,748,750497,500227,600
   > Long-term Assets 
0
0
0
12,513,900
10,472,100
8,676,340
0
0
0
0
00008,676,34010,472,10012,513,900000
       Property Plant Equipment 
13,983,100
12,597,200
10,512,110
10,023,200
9,503,950
8,115,000
6,650,300
6,278,940
6,255,050
6,163,350
6,163,3506,255,0506,278,9406,650,3008,115,0009,503,95010,023,20010,512,11012,597,20013,983,100
       Goodwill 
53,100
67,200
8,960
8,960
8,960
0
0
0
0
0
000008,9608,9608,96067,20053,100
       Long Term Investments 
163,200
102,800
57,500
21,100
0
0
0
0
0
0
00000021,10057,500102,800163,200
       Intangible Assets 
195,400
168,100
230,110
285,640
376,050
165,700
163,600
152,210
138,240
259,410
259,410138,240152,210163,600165,700376,050285,640230,110168,100195,400
       Long-term Assets Other 
0
0
0
1,700
40,280
97,980
0
0
0
0
000097,98040,2801,700000
> Total Liabilities 
14,251,500
14,557,600
13,994,210
14,444,630
12,988,710
10,251,230
11,915,100
14,062,250
8,822,330
4,275,630
4,275,6308,822,33014,062,25011,915,10010,251,23012,988,71014,444,63013,994,21014,557,60014,251,500
   > Total Current Liabilities 
8,268,200
7,060,300
5,671,710
6,856,420
6,910,240
9,382,610
4,167,600
4,490,910
7,763,670
3,318,310
3,318,3107,763,6704,490,9104,167,6009,382,6106,910,2406,856,4205,671,7107,060,3008,268,200
       Short-term Debt 
10,609,400
11,087,800
1,893,180
1,907,120
1,648,800
693,850
35,700
844,460
0
0
00844,46035,700693,8501,648,8001,907,1201,893,18011,087,80010,609,400
       Short Long Term Debt 
10,609,400
11,087,800
11,362,000
11,487,600
3,700,380
6,003,730
0
0
0
0
00006,003,7303,700,38011,487,60011,362,00011,087,80010,609,400
       Accounts payable 
2,521,100
2,091,300
1,878,700
2,392,700
2,771,950
2,697,100
1,988,500
0
0
0
0001,988,5002,697,1002,771,9502,392,7001,878,7002,091,3002,521,100
       Other Current Liabilities 
362,400
206,000
283,700
288,800
228,630
567,360
657,400
0
0
0
000657,400567,360228,630288,800283,700206,000362,400
   > Long-term Liabilities 
0
0
0
8,651,400
6,107,960
898,710
0
0
0
0
0000898,7106,107,9608,651,400000
       Long term Debt Total 
0
0
7,857,110
7,140,610
5,707,080
461,220
6,131,300
7,350,800
341,030
201,640
201,640341,0307,350,8006,131,300461,2205,707,0807,140,6107,857,11000
       Other Liabilities 
139,800
128,700
150,700
177,200
400,880
437,490
1,262,200
0
0
0
0001,262,200437,490400,880177,200150,700128,700139,800
> Total Stockholder Equity
5,127,200
4,549,900
4,035,670
3,556,750
3,086,850
3,503,970
1,987,900
-2,286,930
8,766,360
8,436,030
8,436,0308,766,360-2,286,9301,987,9003,503,9703,086,8503,556,7504,035,6704,549,9005,127,200
   Common Stock
61,300
61,300
61,250
61,250
61,250
61,250
61,300
61,250
61,250
61,250
61,25061,25061,25061,30061,25061,25061,25061,25061,30061,300
   Retained Earnings Total Equity0000000000
   Accumulated Other Comprehensive Income 0000000000
   Capital Surplus 
0
0
919,400
919,400
919,400
919,400
919,400
919,400
919,400
919,400
919,400919,400919,400919,400919,400919,400919,400919,40000
   Treasury Stock0000000000
   Other Stockholders Equity 
5,007,600
5,496,400
-207,700
-133,940
-1,010
45,450
1,926,600
43,280
40,280
57,700
57,70040,28043,2801,926,60045,450-1,010-133,940-207,7005,496,4005,007,600



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue4,599,460
Cost of Revenue-3,107,070
Gross Profit1,492,3901,492,390
 
Operating Income (+$)
Gross Profit1,492,390
Operating Expense-0
Operating Income-57,5301,492,390
 
Operating Expense (+$)
Research Development0
Selling General Administrative2,125,080
Selling And Marketing Expenses0
Operating Expense02,125,080
 
Net Interest Income (+$)
Interest Income117,830
Interest Expense-0
Other Finance Cost-117,830
Net Interest Income0
 
Pretax Income (+$)
Operating Income-57,530
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)128,050-57,530
EBIT - interestExpense = 0
-332,370
-332,370
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0128,050
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax128,050
Tax Provision-465,500
Net Income From Continuing Ops0-337,450
Net Income-332,370
Net Income Applicable To Common Shares-332,370
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net00
 

Technical Analysis of Panacea Biotec Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Panacea Biotec Limited. The general trend of Panacea Biotec Limited is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Panacea Biotec Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Panacea Biotec Limited Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Panacea Biotec Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 435.25 < 480.20 < 495.15.

The bearish price targets are: 397.70 > 282.15 > 278.40.

Know someone who trades $531349? Share this with them.πŸ‘‡

Panacea Biotec Limited Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Panacea Biotec Limited. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Panacea Biotec Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Panacea Biotec Limited. The current macd is -13.18421144.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Panacea Biotec Limited price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Panacea Biotec Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Panacea Biotec Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Panacea Biotec Limited Daily Moving Average Convergence/Divergence (MACD) ChartPanacea Biotec Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Panacea Biotec Limited. The current adx is 16.82.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Panacea Biotec Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Panacea Biotec Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Panacea Biotec Limited. The current sar is 399.22.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Panacea Biotec Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Panacea Biotec Limited. The current rsi is 47.27. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Panacea Biotec Limited Daily Relative Strength Index (RSI) ChartPanacea Biotec Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Panacea Biotec Limited. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Panacea Biotec Limited price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Panacea Biotec Limited Daily Stochastic Oscillator ChartPanacea Biotec Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Panacea Biotec Limited. The current cci is 30.48.

Panacea Biotec Limited Daily Commodity Channel Index (CCI) ChartPanacea Biotec Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Panacea Biotec Limited. The current cmo is 3.9721956.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Panacea Biotec Limited Daily Chande Momentum Oscillator (CMO) ChartPanacea Biotec Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Panacea Biotec Limited. The current willr is -27.563249.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Panacea Biotec Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Panacea Biotec Limited Daily Williams %R ChartPanacea Biotec Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Panacea Biotec Limited.

Panacea Biotec Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Panacea Biotec Limited. The current atr is 20.59.

Panacea Biotec Limited Daily Average True Range (ATR) ChartPanacea Biotec Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Panacea Biotec Limited. The current obv is 4,498,924.

Panacea Biotec Limited Daily On-Balance Volume (OBV) ChartPanacea Biotec Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Panacea Biotec Limited. The current mfi is 43.22.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Panacea Biotec Limited Daily Money Flow Index (MFI) ChartPanacea Biotec Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Panacea Biotec Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Panacea Biotec Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Panacea Biotec Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.267
Ma 20Greater thanMa 50418.090
Ma 50Greater thanMa 100467.831
Ma 100Greater thanMa 200446.431
OpenGreater thanClose418.850
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Panacea Biotec Limited with someone you think should read this too:
  • Are you bullish or bearish on Panacea Biotec Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Panacea Biotec Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Panacea Biotec Limited

I send you an email if I find something interesting about Panacea Biotec Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Panacea Biotec Limited.

Receive notifications about Panacea Biotec Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.